Authors


Erica Smith, PhD

Latest:

Using Machine Learning to Predict Placebo Response and Increase Clinical Trial Success

A look at the prevalence of placebo response in clinical trials and how advanced solutions can mitigate the risk it poses to drug development.


Jane Myles

Latest:

How DCT Technology Can Enable Follow-up Clinical Studies

Research can reveal vital information about treatments in the long run.


Linda Ashmore

Latest:

Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce

2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.


Sarah Taylor

Latest:

eSource Interoperability Between EHR and EDC

Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.




Roberta Ferreira

Latest:

Clinical Study Audits: The Quality Management Approach

Advancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.


Robert A. DiCicco, PharmD

Latest:

Accelerating Clinical Trial Design and Operations

Fully-integrated, component-based CDMS offers flexibility, customization, and efficiency.


Dan Gebow, PhD

Latest:

Transforming Clinical Event Adjudication in the Era of COVID-19

There's no one-size-fits-all approach during the COVID-19 pandemic


Gary A. Kaplan

Latest:

Where Do We Go From Here?

Lessons from six months of conducting clinical trials during the COVID-19 pandemic


Avital Gaziel, PhD

Latest:

Rethinking ECOG Scores to Improve Patient Access and Clinical Trials Eligibility

Recent study results highlight need for new metrics in ECOG scoring to mitigate variability.



Gordon Kessler

Latest:

How a Global Privacy Standard Can Boost Patient Trust

Regulations that apply across geographic borders can provide researchers and patients a firmer foundation on data protection.


Allison Kalloo

Latest:

5 Ways DCTs Can Positively Impact Trial Diversity

COVID-19 forces life sciences industry to make long overdue changes.


Mariel Fabro

Latest:

Advancing COPD Research: Harnessing Wearable Sensors and Remote Monitoring for Improved Insights

Wearable sensors and remote monitoring technology can help HCPs monitor and manage COPD more effectively.


Yannis Jemiai

Latest:

Employing the Power of Bayesian Methods to Expedite Learning

Bayesian methods bring flexibility and speed to clinical trial design and analysis, and with increased access to the necessary computational power, are transforming today’s clinical research.



Simon Jones

Latest:

Clinical Trials Supply Chain: How to Respond to Recent Transformations

Concept of flexibility acting as driving force behind industry’s swift response to COVID-19.


Andrew Hsu

Latest:

Towards Data-Driven Clinical Trial Planning and Strategy

Optimizing feasibility through increased data collection.


Kent Buhler

Latest:

How to Address—and Overcome—Operational Challenges in Master Protocol Studies

Trials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.


Chris Crabtree

Latest:

What Patients Expect from Clinical Trials in the COVID-19 Era

Key takeaways from a survey of 250 oncology patients measuring COVID-19’s impact on patient willingness to participate in clinical trials.


Krystle Karoscik

Latest:

Immunomodulators and Cancer Research

Distinguishing CAR-T and CPI approaches and the clinical trial challenges and complexities associated with each.


Maria I. Florez

Latest:

Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce

2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.


Owen Corbin

Latest:

Confidentiality in DCT: How to Utilize Third-Party Home Health Providers

Alleviating sponsor and investigator concerns around sharing of remote-assessment data in accordance with GCP and GDPR standards.


Jonathan Jackson

Latest:

Importance of Diversity in Parkinson’s Research

Eliminating barriers to engage underrepresented populations.


C.K. Wang, MD

Latest:

Real-World Data Offers Significant Opportunities for Developing New Therapies for Hematologic Cancers

By integrating real-world data more deeply into the process of clinical research, life sciences stakeholders can open up new possibilities for therapeutic development and the evidence-based treatment of hematologic cancers.


Roger Sands

Latest:

WiFi Automation Keeps Decentralized Clinical Trials Running

Reliable internet connection an integral part of movement to DCTs.


Jian Wang, PhD

Latest:

Integration of Point-of-Care Devices in Clinical Trials

A look at the future of clinical trial laboratory testing amid the emerging use of new devices at the point of care.


Megan Hooton

Latest:

Building Relationships Key for Smaller Sponsors

Strong collaboration critical as trial development advances.


© 2024 MJH Life Sciences

All rights reserved.